Compliance with ASCO 2006 recommendations for the use of "white blood cell growth factors" in advanced lung cancer (LC) or breast cancer (BC) or non-Hodgkin lymphoma (NHL): An interim analysis of French National Observational Study—The ZOHé study.
Hubert Orfeuvre
No relevant relationships to disclose
Jean-Loup Mouysset
No relevant relationships to disclose
Omar Benbrahim
No relevant relationships to disclose
Kunlun Liu
No relevant relationships to disclose
Jean-Christophe Eymard
Honoraria - Sandoz
Domitille Fernet
No relevant relationships to disclose
Camille Aubron-Olivier
No relevant relationships to disclose
Henri Hubert Roche
No relevant relationships to disclose
Philippe Solal-Celigny
Consultant or Advisory Role - Sandoz
Toledano Alain
No relevant relationships to disclose
Corinne Haioun
Consultant or Advisory Role - Amgen; Chugai Pharma; Sandoz
Honoraria - Amgen; Chugai Pharma; Sandoz